Skip to Main Content

Paper Details

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
Nature
335
2021
-COs, -LOs, ACE2, COVID-19, SARS, SARS-, SARS-CoV, SARS-CoV-, SARS-CoV-2, alveolar type-II-like cells, colonic cell types, colonic cells, disease, disease-relevant cells, enterocytes, hPSC, hPSC-, hPSC-COs, hPSC-LOs, hPSC-derived colonic organoids, human, human pluripotent stem cells, imatinib, lung, mycophenolic acid, patients, quinacrine dihydrochloride, severe acute respiratory syndrome coronavirus
Author NameAffiliation
Benjamin E Nilsson-PayantIcahn School of Medicine at Mount Sinai
Yaron TomerMeyer Cancer Center
Yaron TomerEnglander Institute for Precision Medicine, Institute for Computational Biomedicine
Tuo Zhang
Alain C Borczuk
Jenny Xiang
Lewis C CantleyMeyer Cancer Center
Benjamin R tenOeverIcahn School of Medicine at Mount Sinai
  • 1 - 8

Datasets

Release 1.2